INREAL - Nintedanib for Changes in Dyspnea and Cough in Patients Suffering From Chronic Fibrosing Interstitial Lung Disease (ILD) With a Progressive Phenotype in Everyday Clinical Practice: a Real-world Evaluation
Clinical trial NCT04702893 · COMPLETED
Trial details
- NCT number
- NCT04702893
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-05-28
- Primary completion
- 2024-04-09
- Enrollment
- 108
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.